Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2012
08/08/2012CN101693669B Minocycline hydrochloride hydrate crystal forms and preparation method thereof
08/08/2012CN101679294B Non-nucleoside reverse transcriptase inhibitors
08/08/2012CN101384604B Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
08/08/2012CN101208102B Immunogenic composition
08/08/2012CN101112618B 疫苗组合物 Vaccine compositions
08/08/2012CN101020055B SARS vaccine based on replicative vaccinia virus vector
08/07/2012US8236851 Dispersed in a polymer; feeding to animals to prevent microbial infection
08/07/2012US8236840 Thiopene containing analogues of fluconazole as antifungal agents and process for their preparation
08/07/2012US8236810 Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV
08/07/2012US8236807 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
08/07/2012US8236803 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
08/07/2012US8236798 Carboxamide compounds and their use as calpain inhibitors
08/07/2012US8236541 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/07/2012US8236487 Tumor specific oligosaccharide sequences and use thereof
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236324 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
08/07/2012US8236292 Low viscosity, non-liquid crystalline mixture comprising tocopherol, diacyl glycerol and phosphatidyicholine for use in treatment of abrasions, oral and genital infections
08/07/2012US8236143 Controlling chemical reactions by spectral chemistry and spectral conditioning
08/07/2012CA2683980C Topical composition comprising n-acetylaldosamines or n-acetylamino acids
08/07/2012CA2550187C Non-nucleoside reverse transcriptase inhibitors
08/07/2012CA2548666C Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
08/07/2012CA2548654C Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
08/07/2012CA2536567C Pharmaceutical and cosmetic formulations for treating fingernails
08/07/2012CA2514992C Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
08/07/2012CA2514930C Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
08/07/2012CA2513544C An otorhinological delivery device
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2457652C Soluble t cell receptor
08/07/2012CA2457414C Virus coat protein/receptor chimeras and methods of use
08/07/2012CA2411927C Immunization of dairy cattle with gapc protein against streptococcus infection
08/07/2012CA2402213C Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
08/07/2012CA2317721C Novel steroid-activated nuclear receptors and uses therefor
08/07/2012CA2309676C Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
08/07/2012CA2286344C Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/02/2012WO2012103361A1 Rsv immunization regimen
08/02/2012WO2012103119A1 Compositions for administering rifalazil and other anti-tuberculosis agents in unit dosage form for oral administration
08/02/2012WO2012103116A1 Pulmonary administration of rifalazil and analogs thereof
08/02/2012WO2012103113A1 Pyrazine and imidazolidine derivatives and their uses to treat hepatitis c
08/02/2012WO2012103011A1 Stable silver oxide formulations
08/02/2012WO2012102793A2 Mammalian genes involved in toxicity and infection
08/02/2012WO2012102679A1 Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
08/02/2012WO2012102404A1 Topical antifungal agent
08/02/2012WO2012102366A1 Method for producing novel piperazine compound
08/02/2012WO2012101846A1 Therapeutic or prophylactic agent for influenza
08/02/2012WO2012101617A1 Antiviral peptides
08/02/2012WO2012101616A1 Antiviral peptides
08/02/2012WO2012101614A1 Antiviral peptides
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012101185A1 Urotensin ii, and urotensin ii receptor agonists for use in the symptomatic treatment of septic shock
08/02/2012WO2012101062A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
08/02/2012WO2012100835A1 Methods and compositions for the treatment of aids
08/02/2012WO2012100436A1 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
08/02/2012WO2012100389A1 Triterpenoid saponin compounds, preparation methods and uses thereof
08/02/2012WO2012100383A1 Refining process of cefamandole sodium
08/02/2012WO2012100302A1 Combination vaccines
08/02/2012WO2012083061A3 Anti-viral compounds
08/02/2012WO2012083053A3 Anti-viral compounds
08/02/2012WO2012083048A3 Anti-viral compounds
08/02/2012WO2012075362A3 Chemokine cxcr4 receptor modulators and used related thereto
08/02/2012WO2012061248A3 Novel specific hcv ns3 protease inhibitors
08/02/2012WO2012058493A3 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
08/02/2012WO2012058363A3 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
08/02/2012WO2012053856A3 Respiratory syncytial virus vaccine composition and method for preparing same
08/02/2012WO2012049327A3 Pesticidal mixtures
08/02/2012WO2012047893A3 Use of rifazil and analogues thereof to treat ocular disorders
08/02/2012WO2012042197A3 Low dose pharmaceutical composition comprising zanamivir
08/02/2012WO2012017349A3 Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
08/02/2012WO2011146527A3 Mammalian genes involved in infection
08/02/2012US20120196930 Topical formulation for diabetic foot ulcers
08/02/2012US20120196908 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same
08/02/2012US20120196906 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors
08/02/2012US20120196890 4-substituted azaadamantane derivatives and methods of use thereof
08/02/2012US20120196887 Methods and compositions for improved rifamycin therapies
08/02/2012US20120196870 Combination therapy and cancer
08/02/2012US20120196859 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
08/02/2012US20120196852 Inhibitors of methionine aminopeptidases and methods of treating disorders
08/02/2012US20120196846 Anti-rsv compounds
08/02/2012US20120196840 Compositions and Methods for Treating, Reducing, Ameliorating, or Preventing Infections
08/02/2012US20120196835 Enzyme inhibiting compounds and methods
08/02/2012US20120196834 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
08/02/2012US20120196830 Kits and improved compositions for treating lower urinary tract disorders
08/02/2012US20120196829 Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
08/02/2012US20120196822 Diyne Compositions
08/02/2012US20120196807 Kidney-targeting drug delivery agent comprising recombinant gelatin
08/02/2012US20120196801 Wound-healing, anti-ambustial, regenerating, and anti-viral pharmaceutical formula for local administration
08/02/2012US20120196794 Combinations of Hepatitis C Virus Inhibitors
08/02/2012US20120196793 Biomarkers for iap inhibitor compounds
08/02/2012US20120196792 Macrocyclic hepatitis c serine protease inhibitors
08/02/2012US20120196791 Combination therapies using antibacterial aminoglycoside compounds
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120195988 Therapeutic Uses for Plants of the Capsicum Genus
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195972 Ophthalmic formulations and uses thereof
08/02/2012US20120195970 Homeopathic Formulations For Treatment Of Herpes Virus Symptoms
08/02/2012US20120195961 Use of Spinosyns and Spinosyn Compositions Against Disease Caused By Protozoans, Viral Infections and Cancer
08/02/2012US20120195960 Post-exposure therapy of influenza a infections
08/02/2012US20120195957 Novel nanoparticle formulations for skin delivery
08/02/2012US20120195937 Polyanionic polymer adjuvants for haemophilus influenzae b saccharide vaccines
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
1 ... 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 ... 1798